Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
- Status
- TERMINATED
- Phase
- PHASE3
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Intravitreal Diclofenac Versus Avastin as Primary Treatment of Diffuse Diabetic Macular Edema
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic Origin
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab for the Treatment of Corneal Neovascularization
- Status
- UNKNOWN
- Phase
- PHASE2
An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Colorectal Cancer RECHALLENGE
- Status
- WITHDRAWN
- Phase
- PHASE2
Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver
- Status
- COMPLETED
- Phase
- PHASE1
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3